Evidence for Sensory Prediction Deficits in Schizophrenia

We used a recently developed force-matching task that allows us to quantify the sensory attenuation of self-produced stimuli (11) (Figure 1). A target force is applied to the subject’s left index finger by a torque motor. Subjects are then required to reproduce the force they just experienced, either directly by pressing with the index finger of their right hand or indirectly by using a joystick controlling the torque motor. Forty right-handed subjects—20 with a DSM-IV diagnosis of schizophrenia and 20 healthy volunteers—participated in the study after providing informed consent and after all experimental protocols were approved by a local ethics board.

The 20 patients and 20 healthy volunteer subjects were well matched for age (patients’ mean age=36.4 years, SD=13.4; volunteers’ mean age=35.9, SD=14), gender (12 in each group were men), handedness, and premorbid IQ (13) (patients’ mean=110, SD=8; volunteers’ mean=114, SD=6). All patients except one were treated with antipsychotic medication, the majority with atypical antipsychotic medication, but all were still moderately symptomatic; their mean score on the Brief Psychiatric Rating Scale (14) was 36. Most patients had prominent positive symptoms: 16 subjects had a score of 4 or more on items related to suspiciousness or hallucinatory behavior. Two participants (one patient and one healthy volunteer) were found to have produced matching forces that did not significantly correlate with the corresponding target forces in either task (r²<0.04, p>0.10). We concluded that they had not properly understood the instructions and removed their data from further analysis.

All participants consistently applied a greater force when using their right index finger to directly match the externally applied target force; they consistently underestimated the force they were applying because their perception of the force was likely to be attenuated. To quantify attenuation in the patients and healthy subjects, we calculated the percentage of the matched force by which the matched force exceeded the target force. The patients were more accurate at the task, showing 27.5% attenuation (Figure 1, red circles), compared with 43.5% in the comparison group (Figure 1, blue circles). When subjects matched the target force using the joystick, both patients and healthy volunteers reproduced the original force much more accurately (Figure 1, diamonds). A repeated-measures two-way analysis of variance (patients versus healthy subjects and direct versus joystick) of the mean matching force normalized by the mean target force showed a significant interaction (F=4.88, df=1, 36, p<0.04). This interaction arose from the patients having significantly less attenuation in the direct force-generation task (simple main effect F=4.71, df=1, 36, p<0.04) but no significant difference from the healthy subjects in the joystick task (simple main effect F=0.16, df=1, 36, p=0.69).

The results show that self-generated forces were attenuated less in the patient group, suggesting a dysfunction in their ability to predict the sensory consequences of their actions. This would be in accord with previous imaging data in the verbal domain (10). Although most of the patients were treated with antipsychotic medication, the absence of any difference between patients and healthy volunteers in the joystick matching task suggests that there was no systematic effect of medication on motor performance; indeed, there was no significant correlation between the chlorpromazine equivalents of medication and the degree of attenuation demonstrated by patients. The present study provides support for the presence of a dysfunctional sensory predictive mechanism in schizophrenia. Future work planned to follow up this interesting finding will concentrate on clarifying the state versus trait nature of this deficit by examining patients longitudinally over time, with changes in symptom profile, and the specificity of this deficit for schizophrenia by examining patients with a diagnosis of bipolar disorder also treated with antipsychotic medication.

Received Sept. 22, 2004; revision received Dec. 17, 2004; accepted Jan. 10, 2005. From the Institute of Neurology, University College London; and the Institute of Psychiatry Kings College London. Address correspondence and reprint requests to Dr. Shergill, Institute of Psychiatry Kings College London, De Crespigny Park, London, SE5 8AF; [email protected] (e-mail). Supported in part by the Wellcome Trust, the McDonnell Foundation, and the Human Frontiers Science Programme.